Skip to content
The Nexus
HEALTHJun 15 · 17:57 UTCMEDPAGE TODAY

Diabetes Patients on Semaglutide Had Fewer Fractures, Study Finds

A study found that diabetes patients using semaglutide (Ozempic, Wegovy) had a 15% lower risk of fractures compared to others with type 2 diabetes. The analysis reviewed medical records and focused on adults with the condition.

Nexus surfaces and summarizes. The full story lives at the source.

Mentioned
semaglutidetopicOzempictopicWegovytopictype 2 diabetestopicFracturestopicMedPage TodayorganizationChicagoplace
Spot something wrong with this article?Report a problem →
Forward this
Related Signal

Adjacent reporting